Q&A

Are Those Glucometer Results Accurate?

Author and Disclosure Information

 

PERFORMANCE REQUIREMENTS FOR GLUCOMETER SYSTEMS
There is no single standard for glucometer accuracy. Per Guideline 15197, issued by the International Organization for Standardization (ISO) in 2013, the minimum criteria for accuracy is at least 95% of blood glucose results within ± 15 mg/dL of the reference value at blood sugar concentrations < 100 mg/dL and within ± 15% at blood sugar concentrations ≥ 100 mg/dL.6 For OTC glucometers, the FDA has recommended that at least 95% of measurements fall within ± 15% and at least 99% of measurements fall within ± 20% of reference values across the entire claimed range of the glucometer system.7

The ISO and FDA both recommend that industry test glucometer accuracy using glucose levels ranging from ≤ 50 mg/dL to ≥ 400 mg/dL.6,7 They also recommend evaluating blood glucose accuracy at different hematocrit levels and assessing accuracy in the presence of interfering substances, such as acetaminophen, ibuprofen, salicylate, sodium, ascorbic acid, bilirubin, creatinine, dopamine, maltose, xylose, galactose, hemoglobin, heparin, L-dopa, methyldopa, triglycerides, cholesterol, sugar alcohols, and uric acid.6,7 The FDA additionally recommends testing glucometer accuracy in the presence of temperature extremes, humidity, and different altitudes.7

Currently, the premarket evaluation of glucometers is a one-time procedure that is typically conducted by the manufacturer. Not all available glucometers currently comply with the less stringent ISO accuracy standards from 2003, and most currently available glucometer systems fail to meet the more stringent accuracy criteria outlined by the ISO in 2013 and the FDA in 2014. Furthermore, there can be inconsistency in the measurement quality between different test strip lots, adding another variable to assessing glucometer accuracy.6

Continue for variables affecting glucometer accuracy >>

Pages

Recommended Reading

Artificial pancreas improved glycemia after islet cell transplant
Type 2 Diabetes ICYMI
Equation Predicts Blindness, Amputation Risk in Diabetes
Type 2 Diabetes ICYMI
U.S. hospitalization rates overestimated for some causes
Type 2 Diabetes ICYMI
Breastfeeding cuts risk of progression from GDM to type 2 diabetes
Type 2 Diabetes ICYMI
Unsupervised, at-home closed-loop insulin delivery system
Type 2 Diabetes ICYMI
AHA: Broadening evidence for CABG over PCI in diabetics
Type 2 Diabetes ICYMI
Blood pressure above 140/80 worsens proteinuric diabetic kidney disease
Type 2 Diabetes ICYMI
AHA: Empagliflozin for T2D reduces heart failure endpoints
Type 2 Diabetes ICYMI
This simple work-day fix helps patients with diabetes
Type 2 Diabetes ICYMI
Blood Pressure Above 140/80 Worsens Proteinuric Diabetic Kidney Disease
Type 2 Diabetes ICYMI

Related Articles